KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -$1.5 million.

  • Exact Sciences' Cash from Financing Activities fell 577.88% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$251.7 million, marking a year-over-year decrease of 208.77%. This contributed to the annual value of $231.9 million for FY2024, which is 45.13% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Cash from Financing Activities is -$1.5 million, which was up 66.06% from -$4.5 million recorded in Q2 2025.
  • Exact Sciences' Cash from Financing Activities' 5-year high stood at $224.6 million during Q2 2024, with a 5-year trough of -$256.2 million in Q1 2025.
  • Over the past 3 years, Exact Sciences' median Cash from Financing Activities value was $92,000 (recorded in 2023), while the average stood at $11.8 million.
  • As far as peak fluctuations go, Exact Sciences' Cash from Financing Activities spiked by 4,784.68% in 2023, and later tumbled by 8,433.34% in 2025.
  • Exact Sciences' Cash from Financing Activities (Quarterly) stood at -$12.2 million in 2021, then surged by 182.84% to $10.1 million in 2022, then declined by 0.65% to $10.0 million in 2023, then grew by 4.60% to $10.5 million in 2024, then slumped by 577.88% to -$1.5 million in 2025.
  • Its Cash from Financing Activities stands at -$1.5 million for Q3 2025, versus -$4.5 million for Q2 2025 and -$256.2 million for Q1 2025.